It could just be that the Nasdaq wants clarification on something. In the case of exchange listed stocks, the exchange deals with problems like these; the SEC only suspends OTC issues.
But if you're thinking of NEWL, its T12 is a bad thing. The company's drowning in toxic conversions and sales. Two reverse splits in the second half of 2013; three so far this year. I think Nasdaq has had enough of NEWL.